La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Shanghai GenTech Salute del bilancio

Salute finanziaria criteri di controllo 5/6

Shanghai GenTech ha un patrimonio netto totale di CN¥3.1B e un debito totale di CN¥879.2M, che porta il suo rapporto debito/patrimonio netto a 27.9%. Le sue attività totali e le sue passività totali sono rispettivamente CN¥8.7B e CN¥5.5B. L'EBIT di Shanghai GenTech è CN¥404.3M rendendo il suo rapporto di copertura degli interessi 489.4. Ha liquidità e investimenti a breve termine pari a CN¥671.2M.

Informazioni chiave

27.9%

Rapporto debito/patrimonio netto

CN¥879.19m

Debito

Indice di copertura degli interessi	489.4x
Contanti	CN¥671.24m
Patrimonio netto	CN¥3.15b
Totale passività	CN¥5.52b
Totale attività	CN¥8.66b

Aggiornamenti recenti sulla salute finanziaria

Does Shanghai GenTech (SHSE:688596) Have A Healthy Balance Sheet?

Jul 29

Recent updates

A Piece Of The Puzzle Missing From Shanghai GenTech Co., Ltd.'s (SHSE:688596) 26% Share Price Climb

Mar 03

Analisi della posizione finanziaria

Passività a breve termine: Le attività a breve termine ( CN¥6.9B ) di 688596 superano le sue passività a breve termine ( CN¥5.1B ).

Passività a lungo termine: Le attività a breve termine di 688596 ( CN¥6.9B ) superano le sue passività a lungo termine ( CN¥420.3M ).

Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: Il rapporto debito netto/patrimonio netto ( 6.6% ) di 688596 è considerato soddisfacente.

Riduzione del debito: Il rapporto debito/patrimonio netto di 688596 si è ridotto da 37.5% a 27.9% negli ultimi 5 anni.

Copertura del debito: Il debito di 688596 non è ben coperto dal flusso di cassa operativo ( 3.9% ).

Copertura degli interessi: I pagamenti degli interessi sul debito di 688596 sono ben coperti dall'EBIT ( 489.4 x copertura).

Shanghai GenTech Salute del bilancio

Salute finanziaria criteri di controllo 5/6

Informazioni chiave

Aggiornamenti recenti sulla salute finanziaria

Does Shanghai GenTech (SHSE:688596) Have A Healthy Balance Sheet?

Recent updates

Investor sentiment deteriorates as stock falls 16%

Does Shanghai GenTech (SHSE:688596) Have A Healthy Balance Sheet?

Shanghai GenTech Co., Ltd. (SHSE:688596) announces an Equity Buyback for CNY 50 million worth of its shares.

Shanghai GenTech Co., Ltd. to Report First Half, 2024 Results on Aug 30, 2024

Sentiment Still Eluding Shanghai GenTech Co., Ltd. (SHSE:688596)

Price target decreased by 9.8% to CN¥46.00

Do Shanghai GenTech's (SHSE:688596) Earnings Warrant Your Attention?

New minor risk - Dividend sustainability

Shanghai GenTech's (SHSE:688596) Profits May Not Reveal Underlying Issues

First quarter 2024 earnings released: EPS: CN¥0.09 (vs CN¥0.04 in 1Q 2023)

Shanghai GenTech Co., Ltd., Annual General Meeting, May 24, 2024

Less than half of directors are independent

Shanghai GenTech Co., Ltd. to Report Q1, 2024 Results on Apr 30, 2024

Returns On Capital At Shanghai GenTech (SHSE:688596) Have Stalled

A Piece Of The Puzzle Missing From Shanghai GenTech Co., Ltd.'s (SHSE:688596) 26% Share Price Climb

Full year 2023 earnings: EPS exceeds analyst expectations

Shanghai GenTech Co., Ltd. (SHSE:688596) announces an Equity Buyback for CNY 50 million worth of its shares.

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 15%

Third quarter 2023 earnings released: EPS: CN¥0.45 (vs CN¥0.33 in 3Q 2022)

Price target decreased by 9.4% to CN¥52.00

Second quarter 2023 earnings released: EPS: CN¥0.52 (vs CN¥0.19 in 2Q 2022)

First quarter 2023 earnings released: EPS: CN¥0.04 (vs CN¥0.04 in 1Q 2022)

Investor sentiment deteriorates as stock falls 16%

Price target decreased by 12% to CN¥50.50

Investor sentiment improves as stock rises 19%

Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Investor sentiment improved over the past week

Third quarter 2022 earnings released: EPS: CN¥0.33 (vs CN¥0.21 in 3Q 2021)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Second quarter 2022 earnings released: EPS: CN¥0.19 (vs CN¥0.23 in 2Q 2021)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Shanghai GenTech Co., Ltd. announced that it expects to receive CNY 300 million in funding

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Shanghai GenTech Co., Ltd. (SHSE:688596) announces an Equity Buyback for CNY 120 million worth of its shares.

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥0.21 (vs CN¥0.09 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.23 (vs CN¥0.17 in 2Q 2020)

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS CN¥0.003 (vs CN¥0.07 in 1Q 2020)

Full year 2020 earnings released: EPS CN¥0.48 (vs CN¥0.45 in FY 2019)

New 90-day low: CN¥15.90

Investor sentiment deteriorated over the past week

New 90-day low: CN¥18.86

New 90-day low: CN¥20.75

Shanghai GenTech Co., Ltd. to Report Q3, 2020 Results on Oct 30, 2020

First half earnings released

Analisi della posizione finanziaria

Storia e analisi del rapporto debito/patrimonio netto

Bilancio

Scoprire le aziende sane